4.8 Letter

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 386, 期 11, 页码 1088-+

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2119912

关键词

-

资金

  1. National Institutes of Health (NIH) [75N93019C00050, U19 AI142790, UM1 AI148689]
  2. Moderna
  3. Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH
  4. Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA) [75A50120C00034]
  5. NIAID [UM1 AI 68614HVTN, UM1 AI 68635, UM1 AI 68618, UM1 AI 68619, UM1 AI 68636, UM1 AI148684-03]
  6. Office of the Assistant Secretary for Preparedness and Response, BARDA [75A50120C00034]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据